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Complimentary and alternative medicine (CAM) is deﬁ ned 
as a “group of diverse medical and health care systems, 
practices, and products that are not presently considered 
to be part of conventional medicine.”1 Complementary 
medicine is used with conventional medicine. Alternative 
medicine is used in place of conventional medicine. There 
are four domains of CAM listed in Table I. Note that herbal 
therapy appears in more than one of the domains.
In 1990, “unconventional medicine” was in use by 34% 
of 1539 adults in a nationwide sample.2 The trend was 
upward with 42% of adults using at least 1 of 16 “alternative 
therapies” by 1997.3 Herbal medicine was in use by 12% of 
the population, highest of the alternative therapies. In the 
2002 National Health Interview Survey (NHIS, n=31044), 
the Alternative Health/Complementary and Alternative 
Medicine supplement indicated 36% of adults used some 
form of “complimentary and alternative medicine” during 
the prior 12 months.4 Although there was not an increase 
in overall use of “complimentary medicine”, there was an 
increase of herbal therapies to 19% of the population.5 Use 
of herbal therapy was related to age (45–64 years old), lack 
of insurance, women, higher education, living in the West, 
using other prescription or over the counter medications, and 
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self-identiﬁ ed as “non-Hispanic other.”6 It appears that use of 
CAM was more common in those with some degree of higher 
education in several surveys. Musculoskeletal conditions 
accounted for 16% of CAM use. Factors that led to the use of 
herbs were because conventional medical treatments were 
too expensive, there was a lack of insurance, concomitant 
poor health, and being 25–44 years old. 
Expenditures for alternative therapies nearly equaled 
those spent on traditional therapy.7 Indeed, 4% of the subjects 
reported using only alternative care during the duration 
of the study. In a study of 547 patients with osteoarthritis 
from Hong Kong, expenditures for alternative therapies 
constituted 5% of the overall personal healthcare spending; 
there was not an improvement in quality of life.8 In addition, 
there was an increase in adverse effects, particularly 
gastrointestinal. Indeed, in a personal experience, one of 
my patients with osteoarthritis returned from Brazil with 
an undeﬁ ned herbal therapy that rapidly led to elevated 
liver function tests. However, in a 1 year followup of 177 
mid-west US rheumatology patients, 22% of CAM users 
discontinued CAM for lack of effectiveness or expense, but 
not for adverse events.9 Perceived efﬁ cacy of CAM is higher 
among those with osteoarthritis than more inﬂ ammatory 
arthritis, such as rheumatoid arthritis.10
Generally, the public believes herbal therapies are safe. 
Reasons include that they are found in nature, many of the 
herbs have been used for centuries, and they are not viewed 
as drugs. However, there are barriers to utilization of CAM.11
Table I
Domains of CAM (extracted from reference 1)
Domain Example Concept Example of technique
Whole medical systems Homeopathy “like cures like” Small and diluted doses of substances
Naturopathy Dietary healing with lifestyle changes Herbs, massage, joint manipulation
Chinese medicine Restore the balance of the yin and yang 
and ﬂ ow of qi
Herbs, meditation, massage, acupuncture
Ayurveda Integrate body, mind and spirit Herbs, massage, yoga
Mind–body medicine Meditation Conscious mental process to relax body 
and mind
Art, music, dance
Biologically based 
practices 
Natural products Herbs, foods, vitamins Dietary supplements, herbal products
Manipulative and 
body-based practices
Manipulation Controlled force to a joint aids in restoring 
health (increase blood and oxygen)
Chiropractic or osteopathic manipulation, 
massage
Energy medicine Bioﬁ eld therapy Affect energy ﬁ elds Pressure, Qi gong, Reiki, Therapeutic Touch
Bioelectromagnetic-
based therapies
Use electromagnetic ﬁ elds Pulsed ﬁ elds, magnetic ﬁ elds, alternating-
current ﬁ elds, direct-current ﬁ elds
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In a study of 601 Stanford University Alumni, disuse of CAM 
was predicted on 1) being a man, 2) being healthy, 3) lack of 
physician support, 4) the belief that CAM treatments were 
ineffective or inferior.
There has been reluctance among the practicing physician 
to accept, much less prescribe, herbal therapy. This may 
be related in part to the lack of control over the dose, lack 
of knowledge of the beneﬁ ts and potential adverse effects, 
concern that there are wide variations in the composition of 
the products from the same manufacturer, wide variations 
in the composition of the products between manufacturers 
and limited information in clinical trials—particularly well 
performed randomized controlled trials. 
An example of concerns involves the potential of 
contaminants with the herbal products. The most commonly 
used ones are ayurvedic herbal medicine products. One in 
5 ayurvedic herbal medicine products produced in South 
Asia, and available in Boston, USA grocery stores, contained 
potentially harmful levels of lead, mercury and/or arsenic.12
Times are changing, as the US Congress has now passed 
legislation requiring manufacturers to notify the US Food 
and Drug Administration (FDA) of adverse reactions to their 
dietary supplements. 
The FDA has now ordered dietary supplement manu-
facturers to follow Good Manufacturing Practices in order 
to omit products containing impurities or contaminants. This 
increase in control, with the requirement that the product 
labels are accurate, is being phased in. Manufacturers are 
aware of the changes in regulations as well as the concerns 
of patients and physicians, and are trying to address them. 
Manufacturers are accepting high quality manufacturing 
standards and are attempting to comply with the FDA 
standards for prescription pharmaceuticals. 
From the physician’s perspective, the history of clinical 
research into herbs and most forms of CAM has been far 
from ideal. Many manufacturers are now putting more interest 
and effort into basic and clinical research into their products. 
Mechanisms of action are being researched. Clinical trials 
are using currently accepted outcome instruments with 
increasing regularity. There is an effort to perform well 
controlled, randomized controlled clinical trials. 
The FDA separates those herbs that are ‘supplemental’ 
from those that ‘replace a dietary deﬁ ciency’. The former are 
considered a food supplement and the latter are considered 
as dietary managements. A single agent has been approved 
as a ‘dietary management’ agent of osteoarthritis. Flavocoxid 
is a ﬂ avonoid that acts by “restoring and maintaining the 
balance of fatty acids in osteoarthritis.”13 Approval was based 
on a 60 patient, 90 day study demonstrating improvement in 
Western Ontario McMaster Universities with the osteoarthritis 
index (WOMAC) subscales for stiffness and function from 
baseline, not from placebo. There was no signiﬁ cant change 
in the pain subscale. Although this level of evidence is less 
than ideal, the safety of the ﬂ avonoid has been established.
There are several herbs that are ‘supplemental’ with data 
showing potential anti-inﬂ ammatory mechanisms in a variety 
of clinical trials. Data on these agents have been summarized 
in several recent reviews.14–16 Many of the products listed 
have demonstrated differences from placebo in appropriately 
conducted and monitored randomized clinical trials. 
In this supplement, data are presented on the potential 
beneﬁ t of rosehip in the treatment of osteoarthritis. In 
addition to the potential mechanism as an anti-inﬂ ammatory 
agent, there are now several clinical trials demonstrating 
beneﬁ t with safety. As we collect more information, herbal 
therapies, like rosehip, will be more readily acceptable 
to the medical community. Until there are more effective 
symptomatic therapies, or until a well established structure 
(disease) modifying agent is available, the clinician needs 
as many safe tools as possible to treat this potentially 
disabling condition. Safe herbal therapies can help to ﬁ ll this 
need.
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